Elon Musk’s Neuralink is making some seriously big moves. It seems like every few months, we’re hearing about new milestones for their brain chip technology. The latest buzz is all about how many people have actually received the implant. As of mid-June 2026, Neuralink has implanted its device in 26 patients! This is a huge jump from the 21 patients reported at the start of the year, showing that they’re really picking up the pace with their human trials.
The Telepathy Device: A New Era for Human-Computer Interaction
You might remember Noland Arbaugh, who was the very first person to get the “Telepathy” device back in early 2024. He’s quadriplegic, but he was able to show the world that he could control a computer cursor, surf the internet, and even post on social media, all just by thinking about it. That was a massive step forward, and it really got people excited about what this technology could do.
Now, Neuralink isn’t just focused on one country. They’ve expanded their trials internationally, with new studies happening in the UAE, the United Kingdom, and Canada. In Great Britain alone, they’ve enrolled seven patients in the GB PRIME study as of May 2026.
Two Key Trials Pushing the Boundaries
Neuralink is running two main studies to test their technology. The first is the PRIME Study. This one is for people who have quadriplegia because of a spinal cord injury or ALS. The goal is to help them control computers and robotic arms using just their thoughts.
The second study is called the VOICE trial. This trial focuses on decoding words from a person’s thoughts. It’s designed for individuals who have severe trouble speaking. Imagine being able to communicate complex thoughts just by thinking them , that’s the aim here.
The Neuralink Implant: Small Size, Big Potential
Let’s talk about the implant itself. It’s pretty small, about the size of a quarter, measuring 23 mm in diameter. Each device can have up to 3,072 electrodes. These electrodes are key to reading and sending signals to the brain.
The U.S. Food and Drug Administration (FDA) has given Neuralink’s technology some important designations. They’ve received “Breakthrough Device Designation” for both their speech restoration technology and their Blindsight project, which aims to restore vision.
Looking Ahead: Automation and Future Goals
Elon Musk has also talked about the company’s future plans. By the end of 2025, he announced that Neuralink planned to start producing the brain-computer interface devices in high volume. They also aim to make the surgical procedure almost entirely automated in 2026.
Getting 26 patients involved in human trials over about 2.5 years is a steady pace for such a new and complex technology. The fact that they are expanding internationally suggests that they are overcoming many of the early hurdles. Elon Musk’s vision is to eventually help thousands of people with severe neurological conditions, and these trials are a critical step in making that happen.
Key Highlights
- Neuralink has implanted its brain chip in 26 patients as of mid-June 2026, a significant increase from earlier in the year.
- The “Telepathy” device allows users to control computers and other devices with their thoughts.
- Noland Arbaugh, the first recipient, demonstrated the ability to control a cursor and use social media via thought alone.
- Trials are expanding globally, with new studies in the UAE, UK, and Canada.
- The PRIME Study focuses on helping individuals with quadriplegia control computers and robotic arms.
- The VOICE trial aims to decode words from thought for those with severe speech impairments.
- The Neuralink implant is small (23mm diameter) and features up to 3,072 electrodes.
- Neuralink has received FDA Breakthrough Device Designation for its vision and speech restoration technologies.
- The company plans for high-volume production and automated surgery in 2026.
FAQ Section
What is Neuralink?
Neuralink is a neurotechnology company founded by Elon Musk. It’s developing implantable brain-computer interfaces (BCIs) to help people with neurological disorders and eventually enhance human capabilities.
How many people have received the Neuralink implant?
As of mid-June 2026, 26 patients have received the Neuralink implant in human trials.
What can people do with the Neuralink implant?
Early trial participants have demonstrated the ability to control computer cursors, browse the internet, play games, and use social media using only their thoughts.
Where are Neuralink trials taking place?
Trials are currently happening in the United States, the United Kingdom, Canada, and the UAE.
What are the future goals of Neuralink?
Neuralink’s long-term goals include restoring function for people with paralysis, blindness, and hearing loss, as well as potentially enhancing human cognitive abilities.
It’s truly amazing to think about the possibilities that Neuralink’s technology opens up. What are your thoughts on these advancements? Let us know in the comments below!
Category: Latest News
Tags: Neuralink, Elon Musk, Brain-Computer Interface, Technology, Medical Breakthrough, Human Trials, Neurotechnology, Healthcare Innovation, Paralysis, ALS
